Citation: | HE Yan-ling, SHEN Dong-lan, PENG An. Oxaliplatin in Combination with Leucovorin and 5-Fluorouracil for Advanced Gastric Cancer[J]. Cancer Research on Prevention and Treatment, 2006, 31(02): 108-109. DOI: 10.3971/j.issn.1000-8578.1040 |
[1] | DING Pingan, YANG Peigang, TIAN Yuan, LIN Yecheng, GUO Honghai, LIU Yang, ZHANG Zhidong, WANG Dong, LI Yong, ZHAO Qun. Clinicopathological Characteristics and Prognosis of Borrmann Type Ⅳ Gastric Cancer[J]. Cancer Research on Prevention and Treatment, 2021, 48(3): 261-267. DOI: 10.3971/j.issn.1000-8578.2021.20.0770 |
[2] | LAI Can-hui, YANG Jian-wei, ZHANG Jiang-ling, CHEN Shao-yi, CHEN Yun-bin, TANG Ming-deng. Study of Value of 18F-FDG SPECT/CT in Evaluation of Treatment Response in Gastric Cancer[J]. Cancer Research on Prevention and Treatment, 2010, 37(06): 679-682. DOI: 10.3971/j.issn.1000-8578.2010.06.019 |
[3] | LIU Lin, GUO Jun, CHEN Zhen, WANG Zhe-hai. Clinical Observation of Taxotere in Combination with 5-Fluorouracil,Leucovorin and Oxaliplatin for Hepatic Metastasis of Gastric Cancer[J]. Cancer Research on Prevention and Treatment, 2007, 34(09): 708-710. DOI: 10.3971/j.issn.1000-8578.2023 |
[4] | ZHAO Yong, GAO Jian-fei, RAO Zhi-Guo, OU Wu-ling, ZHU Yu-ze, DU Guang-zu. Correlation of Cks1, Skp2 and p27 Kip1 Protein Expression in Gastric Cancer[J]. Cancer Research on Prevention and Treatment, 2007, 34(02): 118-120. DOI: 10.3971/j.issn.1000-8578.2410 |
[5] | ZHU Qing-shan, CHEN Ya-min, LIU Ji-wei, YU Pei-yao. Clinical Observation of Oxaliplatin plus 5-fluorouracil Leucovorin in Treatment of Advanced Gastrointestinal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2006, 33(04): 268-269. DOI: 10.3971/j.issn.1000-8578.3380 |
[6] | HAN Zheng, FANG Xiang-ming, XIONG Bi-fang, HU Ji-jun, YU Jie-ping. Relationship between the Expression of hTRTand bcl-2 Protein and Telomerase Activity in Gastric Cancer[J]. Cancer Research on Prevention and Treatment, 2005, 32(02): 85-87. DOI: 10.3971/j.issn.1000-8578.2205 |
[7] | JIN Dong ling, LIU Xian jun, CHAI Xi qing, et al. Significance of cyclinD_2 and p27~(kipl) Expressed in Gastric Carcinoma[J]. Cancer Research on Prevention and Treatment, 2004, 31(02): 76-78. DOI: 10.3971/j.issn.1000-8578.18 |
[8] | PAN Da-chao, XIE Zhong. The clinical study of bimonthly 5-Fluorouracil (5-Fu)/Leucovorin (LV) combined with cisplatin (DDP) in treatment of advanced breast cancer[J]. Cancer Research on Prevention and Treatment, 2002, 29(01): 69-70. DOI: 10.3971/j.issn.1000-8578.132 |
[9] | JIANG Han-guo, YUAN Ming, SHEN Qiang. Significance of p53 protein and PCNA expressed in gastric epithelial dysplasia[J]. Cancer Research on Prevention and Treatment, 2002, 29(01): 46-47. DOI: 10.3971/j.issn.1000-8578.122 |
[10] | Zhao Qian, Cheng Jiaxiang, Hou Jinhui. P53 and nm23 Significance Expression in Human and Its Clinical Gastric Cancer[J]. Cancer Research on Prevention and Treatment, 1999, 26(2): 101-103. |